CureVac N.V. (CVAC)
NASDAQ: CVAC
· Real-Time Price · USD
3.48
-0.11 (-3.06%)
At close: May 09, 2025, 3:59 PM
3.47
-0.43%
After-hours: May 09, 2025, 04:05 PM EDT
-3.06% (1D)
| Bid | 3.33 |
| Market Cap | 784.67M |
| Revenue (ttm) | 535.18M |
| Net Income (ttm) | 162.19M |
| EPS (ttm) | 0.81 |
| PE Ratio (ttm) | 4.3 |
| Forward PE | -12.02 |
| Analyst | Buy |
| Ask | 3.69 |
| Volume | 552,634 |
| Avg. Volume (20D) | 630,004 |
| Open | 3.54 |
| Previous Close | 3.59 |
| Day's Range | 3.40 - 3.58 |
| 52-Week Range | 2.37 - 5.28 |
| Beta | 2.43 |
About CVAC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CVAC
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CVAC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
CureVac N.V. is scheduled to release its earnings on May 22, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
-0.93%
Shares of vaccine stocks are trading lower after C...
Unlock content with
Pro Subscription
1 month ago
+6.43%
CureVac shares are trading higher after the company announced it received a positive validity decision from the European Patent Office in its litigation against BioNTech SE.
2 months ago · accessnewswire.com
CureVac Earns Repeat Recognition by LexisNexis(R) as One of the World's Top InnovatorsCureVac among global top 100 most fast-paced innovators for third consecutive year in acknowledgment of its innovative strength and extensive intellectual property portfolio The company holds one of t...